2,589
Views
8
CrossRef citations to date
0
Altmetric
Research Article

Elastin-derived peptide VGVAPG decreases differentiation of mouse embryo fibroblast (3T3-L1) cells into adipocytes

ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon
Pages 234-245 | Received 21 Feb 2020, Accepted 07 May 2020, Published online: 28 May 2020

References

  • Li DY, Brooke B, Davis EC, et al. Elastin is an essential determinant of arterial morphogenesis. Nature. 1998;393:276–280.
  • Senior RM, Griffin GL, Mecham RP, et al. Val-Gly-Val-Ala-Pro-Gly, a repeating peptide in elastin, is chemotactic for fibroblasts and monocytes. J Cell Biol. 1984;99:870–874.
  • Keith DA, Paz MA, Gallop PM, et al. Histologic and biochemical identification and characterization of an elastin in cartilage. J Histochem Cytochem. 1977;25:1154–1162.
  • Mecham RP, Madaras J, McDonald JA, et al. Elastin production by cultured calf pulmonary artery endothelial cells. J Cell Physiol. 1983;116:282–288.
  • Lin S, Sandig M, Mequanint K. Three-dimensional topography of synthetic scaffolds induces elastin synthesis by human coronary artery smooth muscle cells. Tissue Eng - Part A. 2011;17:1561–1571.
  • Uitto J. Connective tissue biochemistry of the aging dermis. Age-associated alterations in collagen and elastin. Clin Geriatr Med. 1989;5:127–147.
  • Brophy CM, Reilly JM, Smith GJW, et al. The role of inflammation in nonspecific abdominal aortic aneurysm disease. Ann Vasc Surg. 1991;5:229–233.
  • Lapis K, Tímár J. Role of elastin-matrix interactions in tumor progression. Semin Cancer Biol. 2002;12:209–217.
  • Robert L, Robert AM, Jacotot B. Elastin-elastase-atherosclerosis revisited. Atherosclerosis. 1998;140:281–295.
  • Péterszegi G, Robert L. Cell death induced in lymphocytes expressing the elastin-laminin receptor by excess agonists: necrosis and apoptosis. Biomed Pharmacother. 1998;52(9):369–377.
  • Barrett AJ, McDonald JK. Nomenclature: protease, proteinase and peptidase. Biochem J. 1986;237(3):935.
  • Janoff A, Scherer J. Mediators of inflammation in leukocyte lysosomes. IX. Elastinolytic activity in granules of human polymorphonuclear leukocytes. J Exp Med. 1968;128(5):1137–1155.
  • Leake DS, Lieberman GE, Peters TJ. Properties and subcellular localization of adenosine diphosphatase in arterial smooth muscle cells in culture. BBA - Mol Cell Res. 1983;762:52–57.
  • Homsy R, Pelletier-Lebon P, Tixier J-M, et al. Characterization of human skin fibroblasts elastase activity. J Invest Dermatol. 1988;91(5):472–477.
  • Kao RT, Wong M, Stern R. Elastin degradation by proteases from cultured human breast cancer cells. Biochem Biophys Res Commun. 1982;105(1):383–389.
  • Ezure T, Amano S. Increment of subcutaneous adipose tissue is associated with decrease of elastic fibres in the dermal layer. Exp Dermatol. 2015;24(12):924–929.
  • Mochizuki S, Brassart B, Hinek A. Signaling pathways transduced through the elastin receptor facilitate proliferation of arterial smooth muscle cells. J Biol Chem. 2002;277(47):44854–44863.
  • Floquet N, Héry-Huynh S, Dauchez M, et al. Structural characterization of VGVAPG, an elastin-derived peptide. Biopolymers. 2004;76:266–280.
  • Hinek A, Rabinovitch M, Keeley F, et al. The 67-kD elastin/laminin-binding protein is related to an enzymatically inactive, alternatively spliced form of beta-galactosidase. J Clin Invest. 1993;91:1198–1205.
  • Skeie JM, Hernandez J, Hinek A, et al. Molecular responses of choroidal endothelial cells to elastin derived peptides through the elastin-binding protein (GLB1). Matrix Biol. 2012;31:113–119.
  • Ochieng J, Furtak V, Lukyanov P. Extracellular functions of galectin-3. Glycoconj J. 2002;19:527–535.
  • Cantarelli B, Duca L, Blanchevoye C, et al. Elastin peptides antagonize ceramide-induced apoptosis. FEBS Lett. 2009;583(14):2385–2391.
  • Bresalier RS, Byrd JC, Wang L, et al. Colon cancer mucin: A new ligand for the β-galactoside-binding protein galectin-3. Cancer Res. 1996;56:4354–4357.
  • Wang Y, Nangia-Makker P, Tait L, et al. Regulation of prostate cancer progression by galectin-3. Am J Pathol. 2009;174(4):1515–1523.
  • Ochieng J, Warfield P, Green-Jarvis B, et al. Galectin-3 regulates the adhesive interaction between breast carcinoma cells and elastin. J Cell Biochem. 1999;75(3):505–514.
  • Pocza P, Süli-Vargha H, Darvas Z, et al. Locally generated VGVAPG and VAPG elastin-derived peptides amplify melanoma invasion via the galectin-3 receptor. Int J Cancer. 2008;122:1972–1980.
  • Le Page A, Khalil A, Vermette P, et al. The role of elastin-derived peptides in human physiology and diseases. Matrix Biol. 2019;84:81–96.
  • Blood CH, Sasse J, Brodt P, et al. Identification of a tumor cell receptor for VGVAPG, an elastin-derived chemotactic peptide. J Cell Biol. 1988;107:1987–1993.
  • Jung S, Rutka JT, Hinek A. Tropoelastin and elastin degradation products promote proliferation of human astrocytoma cell lines. J Neuropathol Exp Neurol. 1998;57:439–448.
  • Hance KA, Tataria M, Ziporin SJ, et al. Monocyte chemotactic activity in human abdominal aortic aneurysms: role of elastin degradation peptides and the 67-kD cell surface elastin receptor. J Vasc Surg. 2002;35:254–261.
  • Szychowski KA, Gmiński J. Impact of elastin-derived VGVAPG peptide on bidirectional interaction between peroxisome proliferator-activated receptor gamma (Pparγ) and beta-galactosidase (β-Gal) expression in mouse cortical astrocytes in vitro. Naunyn Schmiedebergs Arch Pharmacol. 2019;392:405–413.
  • Takamura T, Nohara E, Nagai Y, et al. Stage-specific effects of a thiazolidinedione on proliferation, differentiation and PPARgamma mRNA expression in 3T3-L1 adipocytes. Eur J Pharmacol. 2001;422:23–29.
  • Vidal-Puig A, Jimenez-Liñan M, Lowell BB, et al. Regulation of PPAR γ gene expression by nutrition and obesity in rodents. J Clin Invest. 1996;97:2553–2561.
  • Gealekman O, Burkart A, Chouinard M, et al. Enhanced angiogenesis in obesity and in response to PPARγ activators through adipocyte VEGF and ANGPTL4 production. Am J Physiol Metab. 2008;295:E1056–64.
  • Kadowaki T, Yamauchi T. Adiponectin and adiponectin receptors. Endocr Rev. 2005;26(3):439–451.
  • Hudak CS, Sul HS. Pref-1, a gatekeeper of adipogenesis. Front Endocrinol (Lausanne). 2013;4:79.
  • Jung UJ, Choi MS. Obesity and its metabolic complications: the role of adipokines and the relationship between obesity, inflammation, insulin resistance, dyslipidemia and nonalcoholic fatty liver disease. Int J Mol Sci. 2014;15:6184–6223.
  • Coelho M, Oliveira T, Fernandes R. Biochemistry of adipose tissue: an endocrine organ. Arch Med Sci. 2013;9:191–200.
  • Scheja L, Heeren J. The endocrine function of adipose tissues in health and cardiometabolic disease. Nat Rev Endocrinol. 2019;15:507–524.
  • Han CY. Roles of reactive oxygen species on insulin resistance in adipose tissue. Diabetes Metab J. 2016;40:272–279.
  • Blaise S, Romier B, Kawecki C, et al. Elastin-derived peptides are new regulators of insulin resistance development in mice. Diabetes. 2013;62:3807–3816.
  • Bako G, Jacob MP, Fulop T, et al. Immunology of elastin: study of anti-elastin peptide antibodies by DOT immunobinding assay. Immunol Lett. 1987;15:187–192.
  • Fülöp T, Wei SM, Robert L, et al. Determination of elastin peptides in normal and arteriosclerotic human sera by ELISA. Clin Physiol Biochem. 1990;8:273–282.
  • Fulop T, Jacob MP, Robert L. Determination of anti-elastin peptide antibodies in normal and arteriosclerotic human sera by ELISA. J Clin Lab Immunol. 1989;30:69–74.
  • Zebisch K, Voigt V, Wabitsch M, et al. Protocol for effective differentiation of 3T3-L1 cells to adipocytes. Anal Biochem. 2012;425:88–90.
  • Gomes A, Fernandes E, Lima JLFC. Fluorescence probes used for detection of reactive oxygen species. J Biochem Biophys Methods. 2005;65:45–80.
  • Nicholson DW, Ali A, Thornberry NA, et al. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature. 1995;376(6535):37–43.
  • Vega-Avila E, Pugsley MK. An overview of colorimetric assay methods used to assess survival or proliferation of mammalian cells. Proc West Pharmacol Soc. 2011;54:10–14.
  • Szychowski KA, Rombel-Bryzek A, Dołhańczuk-Śródka A, et al. Antiproliferative effect of elastin-derived peptide VGVAPG on SH-SY5Y neuroblastoma cells. Neurotox Res. 2019;36:503–514.
  • Szychowski KA, Gmiński J. The VGVAPG peptide regulates the production of nitric oxide synthases and reactive oxygen species in mouse astrocyte cells in vitro. Neurochem Res. 2019;44(5):1127–1137.
  • Robert L, Jacob MP, Frances C, et al. Interaction between elastin and elastases and its role in the aging of the arterial wall, skin and other connective tissues. A review. Mech Ageing Dev. 1984;28(2–3):155–166.
  • Scandolera A, Rabenoelina F, Chaintreuil C, et al. Uncoupling of elastin complex receptor during in vitro aging is related to modifications in its intrinsic sialidase activity and the subsequent lactosylceramide production. PLoS One. 2015;10(6):e0129994. .
  • Gayral S, Garnotel R, Castaing-Berthou A, et al. Elastin-derived peptides potentiate atherosclerosis through the immune Neu1-PI3K pathway. Cardiovasc Res. 2014;102:118–127.
  • Moynagh PN. The interleukin-1 signalling pathway in astrocytes: A key contributor to inflammation in the brain. J Anat. 2005;207(3):265–269.
  • Scheer JM Caspase-1. In: Handbook of proteolytic enzymes. London, UK:Elsevier; 2013. p. 2237–2243.
  • Cho K-A, Suh JW, Lee KH, et al. IL-17 and IL-22 enhance skin inflammation by stimulating the secretion of IL-1β by keratinocytes via the ROS-NLRP3-caspase-1 pathway. Int Immunol. 2012;24(3):147–158.
  • Barker BR, Taxman DJ, Ting JP-Y. Cross-regulation between the IL-1β/IL-18 processing inflammasome and other inflammatory cytokines. Curr Opin Immunol. 2011;23:591–597.
  • Trøseid M, Seljeflot I, Arnesen H. The role of interleukin-18 in the metabolic syndrome. Cardiovasc Diabetol. 2010;9(1):1–8.
  • Wang H, Capell W, Yoon JH, et al. Obesity development in caspase-1-deficient mice. Int J Obes. 2014;38(1):152–155.
  • Membrez M, Ammon-Zufferey C, Philippe D, et al. Interleukin-18 protein level is upregulated in adipose tissue of obese mice. Obesity (Silver Spring). 2009;17:393–395.
  • Patel R, Rinker L, Peng J, et al. Reactive Oxygen Species: The Good and the Bad. In: Filip C, Albu A, editors. Reactive Oxygen Species (ROS) in Living Cells. IntechOpen; 2018. p. 7-20
  • Snezhkina AV, Kudryavtseva AV, Kardymon OL, et al. ROS generation and antioxidant defense systems in normal and malignant cells. Oxid Med Cell Longev. 2019;2019:6175804.
  • Satta J, Laurila A, Pääkkö P, et al. Chronic inflammation and elastin degradation in abdominal aortic aneurysm disease: an immunohistochemical and electron microscopic study. Eur J Vasc Endovasc Surg. 1998;15:313–319.
  • Debret R, Le Naour RR, Sallenave J-M, et al. Elastin fragments induce IL-1beta upregulation via NF-kappaB pathway in melanoma cells. J Invest Dermatol. 2006;126:1860–1868.
  • Kobayashi K, Jokaji R, Miyazawa-Hira M, et al. Elastin-derived peptides are involved in the processes of human temporomandibular disorder by inducing inflammatory responses in synovial cells. Mol Med Rep. 2017;16(3):3147–3154.
  • Szychowski KA, Gmiński J. The elastin-derived peptide VGVAPG does not activate the inflammatory process in mouse cortical astrocytes in Vitro. Neurotox Res. 2020;37(1):136–145.
  • Wang XY, You LH, Cui XW, et al. Evaluation and optimization of differentiation conditions for human primary brown adipocytes. Sci Rep. 2018;8:1–12.
  • Green H, Kehinde O. Sublines of mouse 3T3 cells that accumulate lipid. Cell. 1974;1(3):113–116.
  • Kuri-Harcuch W, Green H. Adipose conversion of 3T3 cells depends on a serum factor. Proc Natl Acad Sci U S A. 1978;75:6107–6109.
  • Kraus NA, Ehebauer F, Zapp B, et al. Quantitative assessment of adipocyte differentiation in cell culture. Adipocyte. 2016;5:351–358.
  • Wang Y, Kim K-A, Kim J-H, et al. Pref-1, a preadipocyte secreted factor that inhibits adipogenesis. J Nutr. 2006;136:2953–2956.
  • Liang X, Kanjanabuch T, Mao SL, et al. Plasminogen activator inhibitor-1 modulates adipocyte differentiation. Am J Physiol - Endocrinol Metab. 2006;290:103–113.
  • Brody R, Peleg E, Grossman E, et al. Production and secretion of adiponectin from 3T3-L1 adipocytes: comparison of antihypertensive drugs. Am J Hypertens. 2009;22(10):1126–1129.
  • Fasshauer M, Neumann S, Eszlinger M, et al. Hormonal regulation of adiponectin gene expression in 3T3-L1 adipocytes. Biochem Biophys Res Commun. 2002;290:1084–1089.
  • Jemai R, Drira R, Fetoui H, et al. Colocynth (Citrullus colocynthis) flesh extract suppresses adipogenesis by down-regulating adipogenic transcription factors and their target genes in 3T3-L1 preadipocytes. Food Nutr Sci. 2018:1014–1028.
  • Stofkova A. Leptin and adiponectin: from energy and metabolic dysbalance to inflammation and autoimmunity. Endocr Regul. 2009;43:157–168.
  • Cohen SL, Halaas JL, Friedman JM, et al. Human leptin characterization. Nature. 1996;382:589.
  • Pedersen O, Bak JF, Andersen PH, et al. Evidence against altered expression of GLUT1 or GLUT4 in skeletal muscle of patients with obesity for NIDDM. Diabetes. 1990;39:865–870.
  • Fasshauer M, Paschke R, Stumvoll M. Adiponectin, obesity, and cardiovascular disease. Biochimie. 2004;86(11):779–784.
  • Holmes DIR, Zachary I. The vascular endothelial growth factor (VEGF) family: angiogenic factors in health and disease. Genome Biol. 2005;6:209.
  • Dikov MM, Ohm JE, Ray N, et al. Differential Roles of Vascular Endothelial Growth Factor Receptors 1 and 2 in Dendritic Cell Differentiation. J Immunol. 2005;174(1):215–222.
  • Hasan AU, Ohmori K, Konishi K, et al. Eicosapentaenoic acid upregulates VEGF-A through both GPR120 and PPARγ mediated pathways in 3T3-L1 adipocytes. Mol Cell Endocrinol. 2015;406:10–18.
  • Gong H, Ni Y, Guo X, et al. Resistin promotes 3T3-L1 preadipocyte differentiation. Eur J Endocrinol. 2004;150:885–892.
  • Haugen F, Jorgensen A, Drevon CA, et al. Inhibition by insulin of resistin gene expression in 3T3-L1 adipocytes. FEBS Lett. 2001;507(1):105–108.
  • Steppan CM, Bailey ST, Bhat S, et al. The hormone resistin links obesity to diabetes. Nature. 2001;409(6818):307–312.
  • Patel L, Buckels AC, Kinghorn IJ, et al. Resistin is expressed in human macrophages and directly regulated by PPARγ activators. Biochem Biophys Res Commun. 2003;300(2):472–476.
  • Ikeda Y, Tsuchiya H, Hama S, et al. Resistin affects lipid metabolism during adipocyte maturation of 3T3-L1 cells. Febs J. 2013;280(22):5884–5895.
  • Way JM, Görgün CZ, Tong Q, et al. Adipose Tissue Resistin Expression is Severely Suppressed in Obesity and Stimulated by Peroxisome Proliferator-activated Receptor γ Agonists. J Biol Chem. 2001;276(28):25651–25653.
  • Gelman L, Fruchart JC, Auwerx J. An update on the mechanisms of action of the peroxisome proliferator-activated receptors (PPARs) and their roles in inflammation and cancer. Cell Mol Life Sci. 1999;55:932–943.
  • Bost F, Aouadi M, Caron L, et al. The role of MAPKs in adipocyte differentiation and obesity. Biochimie. 2005;87(1):51–56.
  • Khatiwala CB, Kim PD, Peyton SR, et al. ECM compliance regulates osteogenesis by influencing MAPK signaling downstream of RhoA and ROCK. J Bone Miner Res. 2009;24(5):886–898.
  • Wang W, Lu S, Li T, et al. Inducible activation of ERK5 MAP kinase enhances adult neurogenesis in the olfactory bulb and improves olfactory function. J Neurosci. 2015;35(20):7833–7849.